Accupressure Weight Loss Points For Significant Weight Reduction

Apply the pressure for the amount of time given, and then end the work with the pressure point with massage on the same area. When you work a pressure point on one side of the body, find the pressure point on the opposite side of the body and work it as well. Where to find the pressure points (watch video) Begin with the pressure points on your ears and follow through with the rest of the pressure points on the body. When you are finished end the session with your ears the same way you began the session. What are acupressure massage beads Acupressure beads are pressure balls that are also used to aid the process of finding the meridian pressure points on the ear. On the ear the meridian points can be close together and not as easy to pinpoint or detect and using acupressure beads assures direct pressure and response.
For the original version including any supplementary images or video, visit http://www.examiner.com/article/accupressure-weight-loss-points-for-significant-weight-reduction

Weight loss led to reduction in inflammation

Women in the trial who were assigned to a weight loss intervention had a goal of 10 percent weight reduction during the course of one year achieved through a diet intervention with or without aerobic exercise . “So this program was highly achievable and reproducible. We are not talking about drastic weight loss,” said McTiernan. The researchers measured levels of C-reactive protein, serum amyloid A, interleukin-6, leukocyte and neutrophil in 439 women. At the end of one year, C-reactive protein reduced by 36.1 percent in the diet-alone group and by 41.7 percent in the diet and garcinia cambogia exercise group. Interleukin-6 decreased by 23.1 percent in the diet group and 24.3 percent in the diet and exercise group.
For the original version including any supplementary images or video, visit http://medicalxpress.com/news/2012-05-weight-loss-reduction-inflammation.html

Easy Weight Loss? Intermittent Calorie Reduction Can Lead To Weight Control

They randomly assigned study participants to one of the three diets: a calorie-restricted, low-carbohydrate diet for two days per week; a low-carbohydrate diet in which participants were allowed to eat unlimited protein and healthy fats, including lean meats, olives and nuts garcinia cambogia for two days per week; and a standard, calorie-restricted Mediterranean diet for seven days per week. After four months, mean reduction in weight and body fat was about 9 pounds with the intermittent approaches; mean reduction in weight and body fat was about 5 pounds with the standard dietary approach. Insulin resistance decreased by 22% with the calorie-restricted, low-carbohydrate diet and by 14% with the low-carbohydrate diet which allowed unlimited protein and healthy fats. Insulin resistance decreased by 4% with the standard Mediterranean diet. Other studies on intermittent calorie-restriction — such as, fasting on alternate days or restricting calories two days a week and eating normally five days a week have shown reduction in weight as well as risk for diseases. Dr.
For the original version including any supplementary images or video, visit http://www.examiner.com/article/easy-weight-loss-intermittent-calorie-reduction-can-lead-to-weight-control

Sleep, stress reduction may help weight loss

Our grandfathers and fathers did not die in warfields to protect bunch of narcissists. March 30, 2011 at 21:09 | Report abuse | Reply tekwrytr The best way to improve sleep is to eliminate caffeine in the afternoon. Coffee in the morning is great, but coffee in the afternoonor caffeinated sodas or diet sodasis directly related to problems sleeping. Moreover, the quality of sleep goes up with a reduction in caffeine in the 8-10 hours before sleep.
For the original version including any supplementary images or video, visit http://thechart.blogs.cnn.com/2011/03/29/sleep-stress-reduction-help-weight-loss/

Health Law May Strain Mental Health System

Genomic Health Announces Colon Cancer Publication Supporting Wider Oncotype DX® Utilization

Effective treatment can have profound implications for those who need the care. When their condition is stabilized as Hill’s now is they can get and keep better jobs, avoid medical problems triggered by unaddressed mental health conditions and avoid situations that lead to criminal charges and/or jail. Over capacity Federal officials estimate that one in four people with no insurance have mental health or substance abuse conditions. They expect 32 million new patients to seek care under the new law. Dr.
For the original version including any supplementary images or video, visit http://www.usatoday.com/story/news/nation/2013/11/03/health-law-may-strain-mental-health-system/3398593/

As ofJune 30, 2013, more than 19,000 physicians in over 70 countries had ordered more than 375,000OncotypeDX tests. The company is based in Redwood City ,Californiawith European headquarters inGeneva, Switzerland. For more information, please visit, http://www.GenomicHealth.com and follow the company on Twitter: @GenomicHealth . To learn more about OncotypeDX tests , visit: http://www.OncotypeDX.com , http://www.mybreastcancertreatment.org and http://www.myprostatecancertreatment.org . This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the potential of the company’s colon cancer test to change medical practice in the treatment of stage II colon cancer; the ability of test to reduce the use of chemotherapy and the direct medical costs associated with treating colon cancer for patients with stage II colon cancer; the applicability of the company’s colon cancer test to stage III colon cancer patients; the ability of the company to secure additional reimbursement for its colon cancer test; the applicability of study results to clinical practice; the ability of the company the timing and results of future studies or clinical trials; the focus and attributes of the company’s product pipeline; the ability of the company to develop additional tests in the future; and the ability of any potential tests the company may develop to optimize cancer treatment. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: risks related to the success of the company’s breast, colon and prostate cancer tests; the company’s ability to increase usage of its tests; the risk that the company may not obtain or maintain sufficient levels of reimbursement, domestically or abroad, for its existing tests and any future tests it may develop; the risks and uncertainties associated with regulation of the company’s tests by the FDA and other regulatory organizations; the company’s ability to compete against third parties; the company’s ability to develop and commercialize new tests; the company’s ability to use next generation sequencing methods to discover and develop novel biomarkers; unanticipated costs or delays in research and development efforts; the company’s ability to successfully commercialize its tests outside of the United States; the results of clinical studies; the applicability of clinical study results to actual outcomes; and the other risks set forth in the company’s filings with the Securities and Exchange Commission, including the risks set forth in the company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2013.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/genomic-health-announces-colon-cancer-130100986.html